Celularity Inc. (Nasdaq: CELU) (the “Company”), a regenerative medicine company developing and commercializing placental-derived technologies, today announced that it has received a formal notice from ...
The global tissue engineered skin substitute market is expected to reach a value of USD 2.4 billion in 2024, with projections indicating a growth to USD 3.5 billion by 2034. The market is anticipated ...
FLORHAM PARK, N.J., Oct. 16, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company, today announced that it had added to its commercial portfolio of ...
We INFORM. We INSPIRE. We EMPOWER. Founded by serial entrepreneur Sonalie Figueiras in 2011, Green Queen is a multi-channel digital news platform and a trusted global impact media brand. Our ...